secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyell Immunopharma, Inc. (LYEL)
CIK:        0001806952
Form:       8-K
Filed at:   2023-09-11T23:59:59+00:00
Accession:  0001193125-23-232064
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyell Immunopharma furnishes investor presentation; no substantive content in filing
--------------------------------------------------------------------------------

- Filing under Item 7.01 announces a September 11, 2023 investor presentation.
- Presentation available on company IR website; attached Exhibit 99.1 lacks slide content.
- No financial data, pipeline updates, or guidance provided in this 8-K.
- Disclosure is routine FD with no material new information for investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1806952/000119312523232064/0001193125-23-232064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1806952/000119312523232064/d506931d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-232064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer